Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Aug 31, 2015 (11 years ago)

ImproVue Ophthalmic Lubricant Drops

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Falied pH specification

Cause type: Failed specification

A physical or chemical test other than potency, dissolution, impurity or stability failed - pH, viscosity, appearance, tablet integrity, fill volume. A product outside its own specification may not perform as designed, even if the active ingredient is present. All failed specification recalls.

What was recalled

ImproVue Ophthalmic Lubricant Drops (1.7% Hypromellose), 1 Single Use Syringe, 0.07 fl oz (2mL), 1 Single Use Applicator Tip per carton, Manufactured for OCULUS SURGICAL, Port St. Lucie, FL 34986, NDC 62144-5510-05

Affected NDC 62144-5510-05

Compare with the code on your package — it is the most precise check available.

Category: Eye Drops & Ophthalmic

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
ImproVue Lubricant
Hypromellose 2208 (15000 Mpa.S)
NDC 62144-5510
17 mg/mL Solution/ Drops
Ophthalmic
Oculus Surgical, Inc. OTC
Recalling firm
Oasis Medical, Inc.
NDC code
62144-5510-05
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1418-2015 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Oasis Medical, Inc.

All 2015 recalls
Class II · Moderate risk

Oasis Tears PF

Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision.

Ongoing Sterility / contamination Oasis Medical, Inc. NDC 42126-6400-1 D-0525-2026
Class III · Low risk

HPMC Visoelastic

Failed pH Specification: It has been determined that the pH of the lots recalled, may not meet specification at expiry.

Terminated Failed specification Oasis Medical, Inc. D-0524-2016
Class III · Low risk

HPMC Visoelastic Topical

Failed pH Specification: It has been determined that the pH of the lots recalled, may not meet specification at expiry.

Terminated Failed specification Oasis Medical, Inc. D-0523-2016
Class III · Low risk

HPMC Visoelastic

Failed pH Specification: It has been determined that the pH of the lots recalled, may not meet specification at expiry.

Terminated Failed specification Oasis Medical, Inc. D-0522-2016

Other failed specification recalls from 2015

All failed specification recalls
Class III · Low risk

Paricalcitol Capsules

Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.

Terminated Failed specification Dr. Reddy's Laboratories, Inc. NDC 55111-665-30 D-0721-2016
Class III · Low risk

Paricalcitol Capsules

Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.

Terminated Failed specification Dr. Reddy's Laboratories, Inc. NDC 55111-664-30 D-0720-2016
Class III · Low risk

Paricalcitol Capsules

Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.

Terminated Failed specification Dr. Reddy's Laboratories, Inc. NDC 55111-663-30 D-0719-2016
Class III · Low risk

HPMC Visoelastic

Failed pH Specification: It has been determined that the pH of the lots recalled, may not meet specification at expiry.

Terminated Failed specification Oasis Medical, Inc. D-0524-2016